Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma.
Ontology highlight
ABSTRACT: Cholangiocarcinoma accounts for approximately 10% of all hepatobiliary tumors and represents 3% of all new-diagnosed malignancies worldwide. Intrahepatic cholangiocarcinoma (i-CCA) accounts for 10% of all cases, perihilar (h-CCA) cholangiocarcinoma represents two-thirds of the cases, while distal cholangiocarcinoma accounts for the remaining quarter. Originally described by Klatskin in 1965, h-CCA represents one of the most challenging tumors for hepatobiliary surgeons, mainly because of the anatomical vascular relationships of the biliary confluence at the hepatic hilum. Surgery is the only curative option, with the goal of a radical, margin-negative (R0) tumor resection. Continuous efforts have been made by hepatobiliary surgeons in order to achieve R0 resections, leading to the progress
SUBMITTER: Lauterio A
PROVIDER: S-EPMC8345178 | biostudies-literature | 2021 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA